Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Endotoxin Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Qureshi, N.
Right arrow Articles by Golenbock, D. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Qureshi, N.
Right arrow Articles by Golenbock, D. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Structure of lipid A and cell activation

Nilofer Qureshi

Mycobacteriology Research Laboratory, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA, Department of Bacteriology, University of Wisconsin, Madison, Wisconsin, USA, Department of Animal Health and Biomedical Sciences, University of Wisconsin, Madison, Wisconsin, USA

Galina Kutuzova

Department of Animal Health and Biomedical Sciences, University of Wisconsin, Madison, Wisconsin, USA

Kuni Takayama

Mycobacteriology Research Laboratory, William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, USA, Department of Medical Microbiology and Immunology, University of Wisconsin, Madison, Wisconsin, USA

Peter A. Rice

Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center and the Boston University School of Medicine, Boston, Massachusetts, USA

Douglas T. Golenbock

Maxwell Finland Laboratory for Infectious Diseases, Boston Medical Center and the Boston University School of Medicine, Boston, Massachusetts, USA

Lipopolysaccharide (LPS) is the principal antigen of Gram-negative bacteria. The free lipid A is derived by mild acid hydrolysis of the LPS. The structures of lipid A from three select sources were compared. The toxic lipid A of Enterobacteriaceae LPS contains 6 fatty acids (C14 or C12) whereas the nontoxic penta-acyl diphosphoryl lipid A derived from the LPS of Rhodobacter sphaeroides (RsDPLA) contains short-chain fatty acids (C10). The nontoxic penta-acyl lipid A from Chlamydia trachomatis contains long-chain fatty acids (C20). This analysis shows that the toxic property of lipid A is determined by the fatty acid composition. Clearly, there is a fine structural requirement for toxicity (and biological activities) of lipid A (including LPS). As an effective antagonist in both human and murine cell lines, RsDPLA is a useful reagent for studying toxic LPS-induced signaling. RsDPLA appears to bind to the putative physiological receptor and does not allow the toxic LPS to bind and initiate signaling. This appears to occur very early at the level of both LBP and CD14. This suggests that RsDPLA may be a useful drug for Gram-negative septic shock.

Journal of Endotoxin Research, Vol. 5, No. 3, 147-150 (1999)
DOI: 10.1177/09680519990050030801


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?